Summary
General Motors Company (GM) announced a significant transaction involving the sale of 40,000,000 shares of its common stock by the UAW Retiree Medical Benefits Trust. This offering, managed by Citigroup Global Markets Inc. and Barclays Capital Inc., closed on March 2, 2018. Importantly, GM itself did not sell any shares and therefore received no proceeds from this offering. The primary impact for investors in this filing is the simultaneous repurchase by GM of 2,518,257 shares of its own common stock from the underwriters at the offering price, which were subsequently retired. This share repurchase action will reduce the total number of outstanding shares. While the company did not directly benefit financially from the sale by the trust, the repurchase of shares signals a potential capital allocation strategy. Investors should note that this event does not alter GM's core business operations but does affect the company's share count, which can influence per-share metrics such as earnings per share (EPS) and book value per share in the future. The filing provides details of the underwriting agreement and related legal opinions, confirming the completion of this transaction.
Key Highlights
- 1UAW Retiree Medical Benefits Trust sold 40,000,000 shares of GM common stock in a public offering.
- 2The offering closed on March 2, 2018, with Citigroup Global Markets Inc. and Barclays Capital Inc. acting as underwriters.
- 3General Motors Company (GM) did not sell any shares and received no proceeds from this specific offering.
- 4GM repurchased 2,518,257 shares of its common stock from the underwriters at the offering price.
- 5The repurchased shares were retired, reducing the total number of outstanding shares.
- 6The transaction involved a material definitive agreement for the underwriting and share repurchase.
- 7Relevant SEC filings, including the underwriting agreement and legal opinions, are included as exhibits.